Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer
暂无分享,去创建一个
B. Edwin | G. Mælandsmo | K. Flatmark | A. Ree | M. Lund-Iversen | S. Yaqub | Å. Fretland | K. Grzyb | V. Dagenborg | S. Marshall | A. H. Ree
[1] A. Cercek,et al. Immunotherapy for the treatment of colorectal cancer , 2021, Journal of surgical oncology.
[2] Yun Wang,et al. Primary tumor immune score fails to predict the prognosis of colorectal cancer liver metastases after hepatectomy in Chinese populations , 2021, Annals of translational medicine.
[3] S. Fox,et al. Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer , 2020, Virchows Archiv.
[4] F. Marincola,et al. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] B. Edwin,et al. Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases , 2020, Cancer biology & therapy.
[6] E. Dekker,et al. Colorectal cancer , 2019, The Lancet.
[7] E. Donnadieu,et al. Obstacles to T cell migration in the tumor microenvironment. , 2019, Comparative immunology, microbiology and infectious diseases.
[8] D. S. Bhullar,et al. Biomarker concordance between primary colorectal cancer and its metastases , 2019, EBioMedicine.
[9] H. Nishikawa,et al. Regulatory T cells in cancer immunosuppression — implications for anticancer therapy , 2019, Nature Reviews Clinical Oncology.
[10] J. Galon,et al. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies , 2019, Nature Reviews Drug Discovery.
[11] A. Siriwardena,et al. The OSLO-COMET Randomized Controlled Trial of Laparoscopic Versus Open Resection for Colorectal Liver Metastases. , 2018, Annals of Surgery.
[12] A. Debucquoy,et al. The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients. , 2018, Cancer cell.
[13] P. Validire,et al. The clinical role of the TME in solid cancer , 2018, British Journal of Cancer.
[14] F. Marincola,et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.
[15] K. Hirakawa,et al. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study , 2018, BMC Cancer.
[16] J. Engstrand,et al. Colorectal cancer liver metastases – a population-based study on incidence, management and survival , 2018, BMC Cancer.
[17] F. Kühnel,et al. CD4 and CD8 T lymphocyte interplay in controlling tumor growth , 2017, Cellular and Molecular Life Sciences.
[18] J. Marsal,et al. Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile , 2017, European Journal of Medical Research.
[19] A. Børresen-Dale,et al. Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases , 2017, Oncotarget.
[20] H. Sakamoto,et al. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. , 2017, Oncology reports.
[21] H. Lee,et al. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer , 2016, Oncotarget.
[22] Chao Lu,et al. Retrospective study , 2016, Medicine.
[23] Morten Wang Fagerland,et al. Open versus laparoscopic liver resection of colorectal metastases: The Oslo-CoMet study , 2016 .
[24] Z. Trajanoski,et al. Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. , 2016, Immunity.
[25] N. Halama,et al. Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration , 2013, Oncoimmunology.
[26] F. Marincola,et al. The immune score as a new possible approach for the classification of cancer , 2012, Journal of Translational Medicine.
[27] Axel Benner,et al. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. , 2011, Cancer research.
[28] Gemma Navarro,et al. Validation microsatellite path score in a population-based cohort of patients with colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[30] D. Littman,et al. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. , 2011, Gastroenterology.
[31] Zlatko Trajanoski,et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Gonen,et al. T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases , 2009, Annals of Surgical Oncology.
[33] Pornpimol Charoentong,et al. Coordination of intratumoral immune reaction and human colorectal cancer recurrence. , 2009, Cancer research.
[34] E. Aandahl,et al. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner , 2008, Cancer Immunology, Immunotherapy.
[35] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[36] J. Hjelmborg,et al. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells , 2003, Cancer Immunology, Immunotherapy.
[37] L H Blumgart,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.
[38] J. Machiels,et al. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival , 2018, Journal of the National Cancer Institute.
[39] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[40] E. Abdalla,et al. New paradigm in the management of liver-only metastases from colorectal cancer. , 2007, Gastrointestinal cancer research : GCR.
[41] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.